SCHEMBL4969155

SCHEMBL4969155

CC(C)C1Oc2c(Cl)cccc2NC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
BRD4 O60885 9/20 0.38
PARP1 P09874 1/20 0.37
CES1 P23141 1/20 0.36
CREBBP Q92793 3/20 0.35
AKR1B1 P15121 1/20 0.35
PBRM1 Q86U86 1/20 0.35
CHRM1 P11229 1/20 0.34
HTR5A P47898 3/20 0.34
HTR1A P08908 2/20 0.34
HTR1D P28221 2/20 0.34
HTR2C P28335 2/20 0.34
HTR7 P34969 2/20 0.34
HTR2A P28223 1/20 0.34
HTR3A P46098 1/20 0.34
HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971260 0.83 BRD4 (0.52) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL4898103 0.82 BRD4 (0.41) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL10359070 0.82 BRD4 (0.38) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL10358533 0.82 BRD4 (0.41) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL528970 0.82 BRD4 (0.38) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL4971589 0.81 LMNA (0.38) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL18128085 0.80 PARP1 (0.56) MEN1KMT2ABRD4PARP1CES1
SCHEMBL31402319 0.80 PARP1 (0.56) MEN1KMT2ABRD4PARP1CES1
SCHEMBL10358737 0.79 NR3C1 (0.38) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL4968933 0.79 BRD4 (0.37) MEN1KMT2AALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1985297-A1 CARBOXYLIC ACID COMPOUND AND USE THEREOF Japan Tobacco, Inc. (JP) 2008-10-29 EP disclosed
US-20070197512-A1 Carboxylic Acid Compounds and Use Thereof JAPAN TOBACCO INC. (JP) 2007-08-23 US disclosed
EP-0243018-B1 THIOLACTAM-N-ACETIC ACID DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1990-10-24 EP disclosed
US-4771050-A ALDOSE REDUCTASE INHIBITOR, ANTICOAGULANTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-09-13 US disclosed
EP-0243018-A1 Thiolactam-N-acetic acid derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-10-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197512-A1 Carboxylic Acid Compounds and Use Thereof GLS, SLC10A1, SOAT1 MEN1 4288/4885KMT2A 1121/4885ALDH1A1 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.